A retrospective study published in the Asian Spine Journal suggests that patients with a history of cannabis use may require fewer opioids after lumbar fusion surgery. Conducted by researchers from Rosalind Franklin University of Medicine and Science, University of Illinois, Yale School of Medicine, and the University of Cincinnati School of Medicine, the purpose of …
Category: Studies
Oct 21 2024
Study: Phytocannabinoids ike CBD and THC May Relieve Anxiety and Fear Triggered by Seizures
According to the results of a new study, phytocannabinoids derived from marijuana, cannabidiol (CBD) and tetrahydrocannabinol (THC), may help manage emotional comorbidities often associated with epilepsy, including anxiety and fear responses. Researchers observed that seizures led to increased anxiety- and fear-like behaviors in rats, but these effects were reversed by administering CBD (via vapor) and …
Oct 21 2024
Study: Psilocybin Reduces Heroin Relapse in Animal Model
A study published recently in the peer reviewed journal Molecular Psychiatry found that psilocybin, a psychedelic compound, may help reduce heroin-seeking behavior. Researchers from Temple University conducted experiments to investigate the potential therapeutic effects of psilocybin on opioid addiction, particularly focusing on relapse behavior following heroin self-administration. In the study, rats were given heroin at …
Oct 18 2024
MDMA Purity Dropped to 15% in 2009, Rose to 74% in 2023, Study Finds
A new study from Georgia State University, published in the journal Drug and Alcohol Dependence, shows that there continues to be issues with misrepresentation of MDMA in unregulated markets across the United States, although there has been improvements in recent years. The research analyzed 4,719 alleged MDMA samples submitted to the DrugsData drug-checking service, aiming …
Oct 18 2024
Cannabidiol Found to Damage Cancer Cells and Halt Growth in Oral Cancer Study
A study set to be published in the journal Archives of Oral Biology in January 2025 explores the potential biological effects of cannabidiol (CBD) on oral squamous cell carcinoma cells. Conducted by researchers from the University of Perugia in Italy, the study examines CBD as a possible adjuvant therapy in cancer treatment. The study was …
Oct 18 2024
Study: Cannabidiol (CBD) Shows Potential to Inhibit Growth and Biofilm Formation of Candida albicans
A recent study published in the Canadian Journal of Microbiology demonstrates that the cannabis compound cannabidiol (CBD) may effectively inhibit the growth of Candida albicans, a yeast commonly associated with infections such as oral candidiasis. Researchers treated C. albicans with varying concentrations of CBD, ranging from 0 to 20 µg/mL, and observed a significant reduction …
Oct 17 2024
Medical Cannabis May Cut Costs in Chronic Pain Treatment, Study Finds
An early economic analysis published in the journal Expert Review of Pharmacoeconomics & Outcomes Research suggests that medical marijuana could provide notable cost savings when treating chronic pain. The study assessed the cost-effectiveness of cannabis-based medicinal products (CBMPs) compared to other treatment options, such as analgesics, physiotherapy, and cognitive behavioral therapy, over a one-year period …
Oct 15 2024
Study: CBD Shows Therapeutic Potential for Gut Health and Related Conditions
A recent literature review published in the journal Cells by explores the multifaceted therapeutic effects of cannabidiol (CBD) on the gastrointestinal (GI) system. This non-psychotropic compound, found in Cannabis sativa, has demonstrated promising modulatory effects across various bodily systems, including the central nervous and immune systems. The review, conducted by researchers from the University of …
Oct 14 2024
Study: CBD Reduces Arsenic-Induced Kidney Damage
Researchers from Ahvaz Jundishapur University of Medical Sciences in Iran have discovered that cannabidiol (CBD) can significantly reduce kidney damage caused by arsenic exposure in mice. Published in the peer-reviewed journal Research in Pharmaceutical Sciences, the study explored how CBD influences specific pathways involved in oxidative stress, inflammation, and cell death, particularly the NOX4 and …
Oct 14 2024
Study of Over 100,000 Finds Maternal Marijuana Use Not Associated With Increased Risk of ADHD or Behavior Disorders in Children
A large-scale study involving over 100,000 participants has found that maternal marijuana use during early pregnancy is not associated with an increased risk of offspring developing attention deficit hyperactivity disorder (ADHD) or disruptive behavior disorders (DBD). The study, titled Prenatal Cannabis Use and Offspring Attention Deficit Hyperactivity Disorder and Disruptive Behavior Disorders: A Retrospective Cohort …